♦ ACRP Certification Exam Prep Course

ACRP Training and Development is currently revising the curriculum of the prep course for the NEW Certification Exam  which will go into effect in January, 2017.   Check this site frequently for updates.

Questions about the prep course?  Call:  1(703) 253-6269, Email:  Arminda Valles-Hall <AValles-Hall@acrpnet.org>




ACRP Certification Exam Prep

Classroom Course

IMPORTANT NOTICE:  All attendees must bring to class the E6 GCP Guidance.   The Guidance is  available online:   http://www.fda.gov/downloads/Drugs/Guidances/ucm073122.pdf


Instruction:  In English.    Q/A: English or Mandarin.

Registration & Breakfast:   8:30 AM  to 9:00 AM

Lecture:   9:00 AM to 4:00 PM

To download the course brochure, please click here (下載課程簡介,請點擊此網址):  Flyer_ACRP Certification Exam Prep Course

This ACRP prep course will be offered at two (2) locations for the March 2015 exam.

Location (1): TaipeiSaturday, January 24, 2015
 (台北榮總, Taipei Veterans General Hospital)

台北榮民總醫院, 台灣台北市北投區, 石牌路⼆段 201號, 中正樓16樓,神經內科會議室。                                             The Conference Room, Department of Neurology, 16th Floor, Chiang Kai Shek Building, Taipei Veterans General Hospital, No.201, Sec. 2, Shipai Rd., Beitou District, Taipei City, Taiwan 11217, R.O.C.

Hotels by the Taipei Veterans General Hospital (住宿分別有天母、北投、士林可以選擇)

士林: http://www1.mcu.edu.tw/Apps/SB/SB_Site.aspx?pageID=489&wcID=9124&redirected=true

天母: http://www.noble-hotel.com.tw/room_ch.php

北投: http://www.leaderhotel.com.tw/doubleone/rooms.asp

Location (2): ChanghuaSunday, January 25, 2015 (Changhua Christian Hospital)  彰化基督教醫院
50060台灣彰化縣彰化市建寶街20號 B1樓 彰化基督教醫院國際培訓中心
Changhua Christian Hospital
International Training Centre of Changhua Christian Hospital
Forte Hotel Changhua, B1F No.20, Jianbao St., Changhua City 50060, Taiwan

Please see Online Registration at the end of this announcement.  Once your registration and your payment are complete, your Registration and Class Location will be confirmed by email.  Should cancellation occur due to unforeseeable circumstances, ACRP will refund the participants.

Trainer: Benny Fok, PhD, CCRC (霍兆邦博士, 香港中文大學內科及藥物治療學系臨床藥理學科研究科學主任), Scientific Officer, Department of Medicine and Therapeutics, The Chinese University of Hong Kong.   ACRP Approved Certification Exam Preparation Course Instructor.

Course Description: This ACRP Certification Exam Preparation classroom course provides guidance on how to prepare for an ACRP Certification exam (e.g., CCRA®, CCRC®, and CPI®) to candidates eligible to take the exam. Familiarize yourself with the format of the exam, tackle example questions, and conduct a personal gap analysis to ensure you are fully primed to earn your ACRP Certification.

This classroom course was prepared by ACRP experts exclusively for Chapters to offer locally, and is taught by a trainer approved by ACRP to teach this course. It includes PowerPoint presentations/hand-outs, interactive classroom exercises, discussions and question-and-answer sessions. No contact hours are offered.

Course Learning Objectives:

(1)  Be able to list and use the benefits of certification to drive their exam preparation efforts

(2)  Be familiar with the question-style and layout of ACRP’s Certification exams, including how to approachtheir multiple-choice format

(3)  Be able to identify and describe at least three strategies for preparing for ACRP’s Certification exams

(4)  Be able to use and reference the five relevant guidelines used to create the ACRP’s Certification exams:

  • ICH E2A—Safety Definitions
  • ICH E6—Good Clinical Practice
  • ICH E8—General Considerations for Clinical Trials
  • ICH E9—Statistical Principles for Clinical Trials
  • The Declaration of Helsinki

(5)  Be able to assess their individual level of readiness by practicing exam questions based on the Detailed Content Outline (DCO) under training conditions (NOT exam conditions)


8.30AM Registration Sign-in and Breakfast
9:00–9.15 Welcome and Introduction
9:15–11:00 Module 1: Objectives, Agenda, Introduction to Certification
11:00–11:15 Refreshment Break
11:15–12:15 Module 2: Overview of the 5 Relevant Guidelines
12:15–1:00PM Lunch provided
1:00–2:30 Module 2 Continued: Overview of the 5 Relevant Guidelines
2:30–2:45 Refreshment Break
2:45–3:45 Module 3: Practice Questions
3:45–4:00 Questions and Answers, Adjourn

Target Audience: Eligible candidates for the CCRA®, CCRC®, and/ or CPI® ACRP Certification Exam.

About ACRP Certification: Applications accepted: Applications for the March 2015 Certification Exam will end February 1, 2015.  The next exam date will be September 2015.

2015 Test Dates:

Spring – Feb 26 to March 21, 2015

Fall – Sept 9 to October 3, 2015

2015 Test Sites:

Beijing, Shanghai, Nanjing, Xian, Fuzhou, Guangzhou, Hong Kong, Malaysia, Singapore, Taipei (2 locations), and Kaohsiung. For more test sites and further details, please visit: https://www.prometric.com/en-us/clients/acrp/Pages/landing.aspx

ACRP Certification, administered by the Academy of Clinical Research Professionals (the Academy), is the formal recognition of clinical research professionals who have met eligibility requirements and demonstrated proficiency of specific knowledge and job‐related skills by passing a standardized exam.

ACRP Certifications are relevant for all research studies involving human subjects, including, but not limited to, drug, device, and biologic studies. Earning and maintaining your credential demonstrates that you have achieved the clinical research profession’s “trusted mark of excellence in clinical research”. This career milestone validates your clinical research knowledge and skills, and the ability to apply those in your daily work.

The CCRA®, CCRC®, and CPI® programs are accredited by the National Commission for Certifying Agencies (NCCA).

For questions about ACRP Certification:  Please contact:  certification@acrpnet.org

Questions About Certification Benefits, Requirements, and Preparation: http://www.acrpnet.org/MainMenuCategory/Certification.aspx


Online Registration for the ACRP Certification Exam Prep Course

The online registration is now closed.  Thank you.

Please check back often for more upcoming events.


♦ (Closed) ACRP-CAP Clinical Research Symposium 2014

Click 2014 Symposium Program_V13 to download a printable program brochure.

  ACRP 2014年度 中國及亞太區  





Clinical Research Symposium 2014

Evolving Challenges of FDA & CFDA:  Multilateral 

Collaboration for the Industry & Regulatory Stakeholders

   Symposium Date:   Saturday, November 8, 2014                            

                                        Attendees Check-in:    Start at 8:15 am                                                

Symposium:  9 am to 4 pm  (Lunch from Noon to 1 pm)

Conference Hotel:   Hong Kong Sheraton Hotel & Towers 20 Nathan Road, TST, Kowloon, Hong Kong,   +852 2369 1111

Official Language:  Presentations in English  Discussions:  English & Chinese


Invitation Letter for Visa Application: Please email ACRPAsiaPacific@gmail.com

Date:     Saturday, November 8, 2014, from 9 am to 4 pm (Breakfast starts at 8 AM.) Conference Hotel:  Hong Kong Sheraton Hotel & Towers 20 Nathan Road, Tsim Sha Tsui (TST), Kowloon, Hong Kong, Click HERE for hotel web site. Hotel Booking:  ACRP Group Rate is HKD $2125 per night for the block of rooms reserved for ACRP, available on a first come first served basis.   To book your hotel room, please specify ACRP conference and email: RES.HongKong@sheraton.com .    Enquiry: rebecca.yu@sheraton.com Other Hotels: Kowloon Hotel, opposite HK Sheraton Hotel.  (Rate is around HKD $1500 per night)
,  19-21 Nathan Road, TST, Kowloon. Hong Kong. E-mail:    enquiry.klnh@harbour-plaza.com Tel: (852) 2734 3777. Web: http://www.harbour-plaza.com/kowloon/Index-en.htm

Morning Session  9:00 – 12:00,  Saturday November 8, 2014

Best Regulatory and Development Practices – FDA, CFDA, and Industry Perspectives

Chair:  Shaoyu Chen (陈少羽律师), Partner; Managing Director, China Food and Drug Practice, Covington & Burling LLP, Beijing    http://www.cov.com/schen/  Chief Compliance Counsel, GE Healthcare China (2010-2011), Beijing, China Senior Counsel, Amgen (2006-2010), Thousand Oaks, California Assistant Chief Counsel, U.S. Food and Drug Administration (2000-2004), Maryland Bio: http://www.cov.com/schen (履历)

Quality of clinical trials is deemed paramount by the regulatory agencies for the protection and welfare of human subjects and patients. As more and more global trials have moved from the West to the East, especially to China, CFDA as well as the FDA have geared up their monitoring and regulatory effort. This session presents several practical considerations from CFDA/CDE experts and their point of view about the China clinical studies, as well as some practical experience from China’s local industry.

Strategy in Drug Development – From Roche Perspective Dr. Qinyong Dai Medical Director, Roche Hong Kong Limited Current Regulatory Practice in China  The certification and registration of medical products with the CFDA can be an extensive and drawn-out process. A large number of documents, specifications and reports must be provided and intensive on-going communication with the certification bodies and testing laboratories is needed. Conducting the registration from overseas can be more difficult due to communication problems and the changes that may arise regarding the requirements of the regulatory bodies.  Get informed about the CFDA certification process and all its single steps by an experienced industry insider.

  • China Regulation System
  • China Regulatory Authority
  • China IND & NDA
  • Communication with Health Authority
  • China GCP & Clinical Trial
  • Traditional Chinese Medicine Registration in China

Wendy Yan, MBA, Senior Vice President, Head of Regulatory Affairs, BeiGene (Beijing),  Global Regulatory Strategist (2010-2014), Regulatory Affairs Director for China (2008-2010) Bayer Healthcare Responding to the Evolving Regulatory Environment Shaoyu Chen, LLB, JD (Bar Admission: District of Columbia) Partner; Managing Director China Food and Drug Practice Covington & Burling LLP, Beijing Noon to 1:00   Lunch (Ming Room I & Ming Terrace)  

Afternoon Session  1:00 – 4:00 , Saturday November 8, 2014

Key Factors on Improving the Efficiency of Clinical Trial Study Quality and Analysis

Chair:  Professor Benny Chung-Ying Zee, PhD  (徐仲锳教授),  Assistant Dean (Research), Professor/Head Division of Biostatistics, Director, Centre for Clinical Research & Biostatistics, Faculty of Medicine, Chinese University of Hong Kong

Biostatistics informs the Food and Drug Administration’s regulatory decision-making processes for premarket review of investigational drugs and devices and post-marketing surveillance of medical products, including decisions to require safety labeling changes and withdraw approval.

The efficiency of the whole clinical trial data process cycle of collecting, analyzing and reporting data was influenced by multiple factors.  This presentation will discuss the effort of data standardization, data quality control and assessment through risk-based monitoring and fraud detection, and the data analysis automation and visualization on the clinical trial study. Many industry insiders do not fully understand the recent guidelines from the FDA, ICH and other professional authority. A SAS specialist will discuss statistical analysis pertinent to ethics, litigation, and regulatory issues.

Dr. Wenjun Bao, Chief Scientist and R&D Manager for JMP Life Sciences of SAS Inc.

How GCP Impacts the Medical Product Review and Approval Decisions: GCP (human studies covered by an IND or IDE) and product applications (510k/PMA/NDA) for marketing approval

Chair:  Dr.  C K Kwan, MB, ChB, FRCR, FHKCR, FHKAM, CPI, MPM (關仲江醫生), Specialist in Clinical Oncology, Queen Elizabeth Hospital, Hong Kong

  • Patient Safety: Principles and practice – An overview from the FDA Consumer Safety Officer
  • Bioresearch Monitoring Program (BIMO) – the protection of research subjects and the integrity of research data in support of marketing approval.
  • Recent trends in BIMO inspections of clinical investigators, IRBs, sponsors, and CROs.
  • Key strategies for responding to FDA 483s and Warning Letters.
  • FDA guidances & the regulation maze: practical considerations for the developers and manufacturers of electronic medical products and health monitoring devices.

Francis Eng, Assistant Director FDA China Office, Shanghai

Continuing Medical Education & Professional Development Accreditations:

Five CME and ACRP contact hours have been applied for through ACRP Global Headquarters. Membership is not required for online registration/application of contact hours.   Updated information will be posted upon approval.


Please select one of the 3 methods to register for the ACRP clinical research symposium.   Please register early to reserve your space.   Deadline for online / wire / mail registration:  Oct. 31.

(1)  Online registration (Due to Singapore regulations, Singapore users please use Option 2 or 3.)  To register online, please click on the appropriate Buy Now button below.

Registration fee is USD $100 :

Discount for a Group > 3:  Please register and pay online for 3, add the name of the 4th person in “Instructions from Buyer", and email:  Info@acrpcap.org

          (2)  Register by EMAIL and Pay Fees by Electronic Transfer:  

Please wire remittance to: Bank of Communications, Hong Kong.  Account No. 027 578 93016220,  Account Name:  Association of Clinical Research Professionals (Please do not use abbreviations.)

(3)  Mail your contact information ( name, address and email address of each attendee) and a crossed cheque with the proper amount of registration fees to:    Association of Clinical Research Professionals, GPO 7762, Central, Hong Kong

PROPER IDENTIFICATION IS REQUIRED.   Please bring your email confirmation to the event.

Terms and Conditions1.  Registration is confirmed only upon receipt of payment. All successful registrations will receive a confirmation from ACRP-China & Asia Pacific Region via e-mail. ACRP reserves the final right of decision if there is any dispute.Cancellation Policy: No refunds are made upon confirmation. Substitutes are acceptable with written notice to ACRP-China & Asia Pacific Region at least 3 days prior to the event date of November 8, 2014.